Literature DB >> 12363168

National Hepatitis C Surveillance Day in the Veterans Health Administration of the Department of Veterans Affairs.

Gary A Roselle1, Linda H Danko, Stephen M Kralovic, Loretta A Simbartl, Kenneth W Kizer.   

Abstract

Hepatitis C is a major public health and financial issue in health care. On March 17, 1999, a Veterans Health Administration (VHA) Hepatitis C Surveillance Day (HepCSD) was undertaken as an administrative tool to estimate the prevalence of hepatitis C antibody positivity in the population served by the VHA for purposes of resource needs allocation and cost projections. This was accomplished using blood from patients who were to have blood drawn for any other purpose. Data were gathered using a national electronic data-extraction system. Of 26,102 tests for hepatitis C virus antibody (HCVAb) performed that day, 1,724 were positive for HCVAb (6.6%). The mean age was 53.8 years, 58.7% were from the Vietnam era, 46% reported as white non-Hispanic, 29% reported as black non-Hispanic, and 97.4% were male. Compared with those who agreed to be tested and who were not seropositive for HCVAb and all persons having contact with the VHA on HepCSD, those who were HCVAb positive were more likely to be younger, black non-Hispanic, and to have served during the Vietnam era. The VHA has identified a target population for further screening and intervention efforts for hepatitis C.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12363168

Source DB:  PubMed          Journal:  Mil Med        ISSN: 0026-4075            Impact factor:   1.437


  11 in total

1.  Risk factors for hepatitis C infection among Vietnam era veterans versus nonveterans: results from the Chronic Hepatitis Cohort Study (CHeCS).

Authors:  Joseph A Boscarino; Alexandra Sitarik; Stuart C Gordon; Loralee B Rupp; David R Nerenz; Vinutha Vijayadeva; Mark A Schmidt; Emily Henkle; Mei Lu
Journal:  J Community Health       Date:  2014-10

2.  Living with hepatitis C: qualitative interviews with hepatitis C-infected veterans.

Authors:  Erik J Groessl; Kimberly R Weingart; Robert M Kaplan; Jack A Clark; Allen L Gifford; Samuel B Ho
Journal:  J Gen Intern Med       Date:  2008-09-20       Impact factor: 5.128

Review 3.  Estimating the true prevalence of hepatitis C in rhode island.

Authors:  Elizabeth N Kinnard; Lynn E Taylor; Omar Galárraga; Brandon D L Marshall
Journal:  R I Med J (2013)       Date:  2014-07-01

4.  Clinical significance of perihepatic lymphadenopathy in patients with chronic hepatitis C infection.

Authors:  Shahriar Tavakoli-Tabasi; Sheeba Ninan
Journal:  Dig Dis Sci       Date:  2011-01-23       Impact factor: 3.199

5.  Racial differences in the evaluation and treatment of hepatitis C among veterans: a retrospective cohort study.

Authors:  Christine M Rousseau; George N Ioannou; Jeffrey A Todd-Stenberg; Kevin L Sloan; Meaghan F Larson; Christopher W Forsberg; Jason A Dominitz
Journal:  Am J Public Health       Date:  2008-04-01       Impact factor: 9.308

6.  Analysis of a hepatitis C screening programme for US veterans.

Authors:  I A Zuniga; J J Chen; D S Lane; J Allmer; V E Jimenez-Lucho
Journal:  Epidemiol Infect       Date:  2006-04       Impact factor: 2.451

7.  The impact of chronic hepatitis C and co-morbid illnesses on health-related quality of life.

Authors:  Jeffrey W Kwan; Ruth C Cronkite; Antony Yiu; Mary K Goldstein; Lewis Kazis; Ramsey C Cheung
Journal:  Qual Life Res       Date:  2008-04-22       Impact factor: 4.147

Review 8.  Current challenges and possible solutions to improve access to care and treatment for hepatitis C infection in Vietnam: a systematic review.

Authors:  Alessandra Berto; Jeremy Day; Nguyen Van Vinh Chau; Guy E Thwaites; Ngoc Nghiem My; Stephen Baker; Thomas C Darton
Journal:  BMC Infect Dis       Date:  2017-04-11       Impact factor: 3.090

9.  Substitution of the CD81 Binding Site and β-Sandwich Area in E2 of HCV in Cambodia.

Authors:  Chikako Yamamoto; Shintaro Nagashima; Channarena Chuon; Ko Ko; Son Huy Do; Oline Lim; Sirany Hok; Somana Svay; Junko Matsuo; Keiko Katayama; Kazuaki Takahashi; Junko Tanaka
Journal:  Viruses       Date:  2020-05-16       Impact factor: 5.048

10.  Experiences with interferon-free hepatitis C therapies: addressing barriers to adherence and optimizing treatment outcomes.

Authors:  Avy A Skolnik; Amanda Noska; Vera Yakovchenko; Jack Tsai; Natalie Jones; Allen L Gifford; D Keith McInnes
Journal:  BMC Health Serv Res       Date:  2019-02-01       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.